7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Adlai Nortye Ltd.
(NASDAQ:ANL) 

ANL stock logo

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent ...

Founded: 2004
IPO Price: $23 (Sep 29, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
Adlai Nortye . Days Payable Outstanding ttm (DPO)
202311 202312 202401 202402 202403 202404 0746.171,492.352,238.522,984.693,730.874,477.045,223.22
Adlai Nortye . Days Inventory Outstanding ttm (DIO)
202311 202312 202401 202402 202403 202404 000000.010.010.01
Adlai Nortye . Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -0.49-0.42-0.35-0.28-0.21-0.14-0.07-0
Adlai Nortye . Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -0.49-0.42-0.35-0.28-0.21-0.14-0.070
Adlai Nortye . Cash Per Share ttm
202311 202312 202401 202402 202403 202404 00.230.460.690.921.151.381.61
Adlai Nortye . (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -10.35-8.87-7.4-5.92-4.44-2.96-1.480
Adlai Nortye . P/B ratio ttm
202311 202312 202401 202402 202403 202404 -2.56-2.19-1.83-1.46-1.1-0.73-0.370
No extra charts and metrics for this ticker.